( click to enlarge )Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Although the exponential moving averages of stock are showing weakness, as the stock is still trading below 50&200 EMAs, there is one technical indicator showing some strength, the MACD. The stock has chance to start new rally, because MACD fast line is about to cross above the MACD slow line. Plus, A/D is also starting to turn up. The stock at least can hit the 13-day EMA at $100.59 per share. Watch to see what it does here.
( click to enlarge )Lpath, Inc. (NASDAQ:LPTN) broke out of a consolidation range on Tuesday, as the stock closed up 4c or 18% on heavy volume, closing above the 50-day EMA for the first time in months. The technical chart shows the buyers are back and a possible test of July high at 36c is very likely. So, keep an eye on it. LPTN has a catalyst ahead: The company announced that data from the Nexus Phase 2 study of iSONEP™ will be presented at the upcoming American Academy of Ophthalmology (AAO) Annual Meeting Retina Subspecialty Day in Las Vegas, Nevada on Saturday.
( click to enlarge )Nice breakout on ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) on decent volume. Buyable on a pullback to the pivot.
( click to enlarge )Arrowhead Research Corp (NASDAQ:ARWR) needs to take out $5.54. The break of the resistance with heavy volume should be the next buy point.
Disclaimer : This is not an investment advisory, and should not be used to make investment decisions. Information in AC Investor Blog is often opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved of the information contained herein. There is no express or implied solicitation to buy or sell securities. The charts provided here are not meant for investment purposes and only serve as technical examples. Don't consider buying or selling any stock without conducting your own due diligence.
Thanks for visiting AC Investor Blog.
AC
